Rick Bright, a member of presumptive President-elect Joseph R. Biden’s COVID-19 advisory board, said Wednesday that the delayed presidential transition process “very likely” could hamper the effective roll-out of a coronavirus vaccine.
“It is absolutely critical that the transition team is able to sit down with the current administration today to be able to discuss the protocols of the trials, the technical aspects of the vaccine and the roll-out and the distribution campaigns,” Mr. Bright said on MSNBC’s “Morning Joe.”
He said they have “no insight” on the plans from the current administration.
“We do not even have direct access to the data,” he said.
The General Services Administration has not yet recognized Mr. Biden as the apparent winner of the election, which would unlock additional resources for the transition and enable Mr. Biden’s team to coordinate directly with the Trump administration.
Multiple media outlets projected Mr. Biden as the winner on Nov. 7, but Mr. Trump hasn’t conceded and